A Protein Sequence Associated With Huntington’s Disease May Become Life-Saving Vaccine Component, Cure Lab, Inc. and Boston University School of Medicine Scientists Say
EurekAlert -- On June 10, 2008 the scientific journal "Vaccine" published a paper by the Massachusetts based biotech company Cure Lab, Inc., demonstrating that a protein sequence important in neurodegenerative Huntington's disease can be safely used as a new generation of vaccine adjuvants.